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Super-enhancers are defined as cluster of enhancers with 
dense TF binding, which can activate proximal cell-identity 
gene expression. Here we review the identification, func-
tional significance of super-enhancers, and their relation-
ships with cancer. With the current intense interests in su-
per-enhancers, more super-enhancers will be defined and 
studied in different cell types and tissues and in different 
developmental and biological contexts to reveal molecular 
mechanisms of their functions. 
ENHANCERS 
Transcription is mainly regulated by transcription factors 
(TFs) binding at specific DNA sequences to recruit RNA 
polymerase II initiation or elongation factors. The most 
studied sites are promoter regions, which harbor transcrip-
tion initiation sites. There are also some DNA sequences 
near or far away from promoter regions, which contain mul-
tiple transcription factor binding sites. Those DNA se-
quences are referred to as “enhancers”.  
The first time the term “enhancer” appeared was in 1981. 
Julian Banerji et al. found that rabbit β-globin gene expres-
sion was enhanced by the SV40 DNA sequence at a dis-
tance without orientation (Banerji et al., 1981). Based on the 
detection of β-globin genes, Grosveld et al. further explored 
the feature of enhancer by constructing “minilocus” con-
sisting of β-globin genes and an enhancer region (Grosveld 
et al., 1987). Since then, functional enhancers were detected 
in a limited scale for a long time. Recently with the devel-
opment of high throughput sequencing, more and more en-
hancers were detected in a genome-wide scale. 
Acetyltransferase P300, a coactivator to increase expres-
sion of its target gene, has been used to detect enhancer in 
mouse embryonic forebrain, midbrain and limb tissue (Visel 
et al., 2009). Meanwhile, histone modification like 
H3K4me1 has been found to be a unique enhancer mark 
(Heintzman et al., 2007). According to the studies done in 
mouse embryonic stem cell (ESC) and adult tissues, en-
hancer with H3K4me1 can be divided into active and inac-
tive/poised states based on whether it is marked by 
H3K27ac or not. In addition to P300 and histone modifica-
tions, DNase hypersensitive sites also partially overlap with 
enhancer regions.   
WHAT IS A SUPER-ENHANCER? 
In Drosophila, the eve gene is auto-regulated by distal 
cis-regulatory region, and different cis-sequence within the 
distal cis-regulatory region function differently in the initia-
tion of different stripes (Harding and Levine, 1988), which 
gives a prototype of super-enhancers that we will discuss 
below. 
Super-enhancer was first proposed as a large genomic 
domain constitute of cluster of enhancers occupied by mas-
ter transcription factors at genes that control pluripotent 
states of mouse ESC (mESC) (Whyte et al., 2013). It is dif-
ferent from typical enhancer in size, transcription factor 
binding density and sensitivity to perturbation. Then the 
definition of super-enhancer was refined as the following. 
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First of all, identify constituent enhancers as master regula-
tor enriched regions, and then constituent enhancers within 
12.5 kb are merged into a larger region. Next, normalized 
Med1 ChIP-seq signals are ranked to generate a curve on 
the signal to rank plot, and a line with a slope of 1 tangent 
to the curve is used as a cutoff to separate super-enhancer 
above the point and typical enhancer below the point of 
tangency (Hnisz et al., 2013; Loven et al., 2013; Whyte et 
al., 2013). Thereafter, super-enhancers are defined in many 
cells and tissues by tissue-specific master transcription fac-
tors. However, master transcription factors for most cells 
are not known, alternatively, one can use marks that rou-
tinely used to identify typical enhancers, such as H3K27ac, 
H3K4me1, p300 and DNase hypersensitivity, to define su-
per-enhancers. Among these marks, H3K27ac has been 
shown to perform the best in mESC. Figure1 shows an ex-
ample of super enhancers, a super-enhancer over the Sox2 
gene, defined with histone mark H3K27ac in different 
mouse tissues. Furthermore, if these alternative ways are 
used to define super-enhancer and then master regulator 
might be inferred in many different cell types based on TF 
binding profiles or motifs. For cells such as ESCs, myo-
tubes, Th cells, pro-B cells and macrophage with known 
master regulators, majority of the master TFs were captured 
by H3K27ac, and candidate master TFs for other cell types 
and tissues were found through analysis in 86 human cell 
and tissue samples (Hnisz et al., 2013). As TFs on su-
per-enhancer are highly coordinately regulated, combining 
these factors in a reasonable way may lead to a more com-
prehensive detection of super-enhancers (Hnisz et al., 
2013). 
FUNCTIONS OF SUPER-ENHANCERS 
In mESC, a super-enhancer was first defined as cluster of 
enhancers occupied by OCT4, SOX2 and NANOG and oth-
er mediators, in addition, Denes Hnisz et al. found that tar-
geting TFs of Wnt (TCF3), TGF-β(SMAD3) and LIF 
(STAT3) signaling pathways, which are critical for stem 
cell state control, bound to individual constitute enhancers 
inside super-enhancers with similar pattern as OCT4, SOX2 
and NANOG. Furthermore, super-enhancer associated 
genes are sensitive to the perturbation of these signaling 
pathways. Therefore, super-enhancers may function as a 
platform for dense transcription factor binding of different 
singling pathways to determine cell identity (Hnisz et al., 
2015). In skin stem cell, pioneer factors such as SOX9 can 
sense slight changes in microenvironment, and then trans-
duce the signal to establish new super-enhancers. Through 
such a mechanism or signal transduction, skin stem cells 
can pursue distinct lineages, repair wounds and exhibit plas-
ticity in transitional states (Adam et al., 2015).  
Enhancer RNAs (eRNA) are “linkers” between su-
per-enhancers and the activation of target gene expression. 
Transcripts coordinately regulated within a super-enhancer 
unit through eRNAs can be mapped by active RNA poly-
merase II global nuclear run-on sequencing (GRO-seq) ex-
periments. About 30.6% of typical enhancers and 93.3% of 
super-enhancers overlap with eRNA in intergenic regions. 
In response to Toll-like receptor signaling in macrophage, 
super-enhancer associated genes and super-enhancer asso-
ciated eRNA show coordinated changes. However, these 
signal-dependent super-enhancers are different from the 
cell-identity determined super-enhancers, with the former 
related with innate immunity and inflammation (Hah et al., 
2015).  
In summary, super-enhancer can not only control cellular 
identity by activating cell-type specific signaling pathways, 
but also respond to stimuli and repress cell maintenance 
related genes through TF redistribution or eRNA coopera-
 
 
Figure 1  Visualization of H3K27ac signal on a super-enhancer over the Sox2 gene in different mouse tissue annotated by Super-Enhancer Archive (SEA) 
(Wei et al., 2016). 
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tion. Super enhancers as dynamic regulatory elements play 
an import role in cell identity control and response to envi-
ronment (Hah et al., 2015). 
SUPER-ENHANCERS AND CANCER 
Super-enhancers were first associated with tumorigenesis 
when they were defined in a myeloma cell line (Loven et 
al., 2013). Loven et al. found that BRD4 inhibition by the 
small molecule JQ1, can selectively repress MYC expres-
sion by decreasing BRD4 binding at MYC super-enhancer 
regions. Further study reveals that some oncogenes, like 
MYC, acquire specific super-enhancers in multiple myelo-
ma tumor cells compared with healthy cells (Hnisz et al., 
2013). 
The TAL1 oncogene is overexpressed in many samples 
of T cell acute lymphoblastic leukemia (T-ALL), but the 
reason was unknown. Mansour et al. found that one of 
TAL1 upstream super-enhancers contains a heterozygous 
12-bp insertion, which made it possible for transcription 
factor MYB to bind (Mansour et al., 2014). CBP, 
CREB-binding protein, was known to promote H3K27ac at 
enhancer regions. The co-binding of CBP and MYB was 
found in most of the super-enhancer regions in Jurkat cells. 
Another case is for THZ1, a covalent inhibitor of CDK7, 
while CDK7 is known to promote transcription activation 
through phosphorylation of RNA Pol II. Chipumuro et al. 
found that in neuroblastoma cells MYCN was associated 
with the largest super-enhancer. THZ1 treatment can reduce 
both mRNA and protein levels of MYCN by decreasing 
RNA Pol II binding at those super-enhancer regions 
(Chipumuro et al., 2014). 
Taken together, these data suggested that some su-
per-enhancers can promote oncogene overexpression. Dis-
rupting the structure of such super-enhancers or inhibiting 
the cofactors involved in the formation of super-enhancers 
provides new routes for cancer therapy. 
DIFFERENCE BETWEEN SUPER-ENHANCERS 
AND OTHER BROAD EPIGENETIC MARKS 
Super-enhancers can be defined with histone mark 
H3K27ac (Hnisz et al., 2013). Several other large epigenetic 
marks are also found to be related with cell identity or tissue 
specific functions, such as H3K4me3 broad peaks 
(Benayoun et al., 2014; Chen et al., 2015) and DNA meth-
ylation valleys (large hypo-methylate regions) (Jeong et al., 
2014; Xie et al., 2013). Evidence shows that those different 
broad epigenetic marks marked different sets of genes from 
those marked by super-enhancers, even though they overlap 
in some genomic regions. For example, both H3K4me3 
broad peaks and super-enhancers marked stem cell regula-
tors in mESC (Benayoun et al., 2014). But further analysis 
shows that H3K4me3 broad peaks have better discrimina-
tive power for cell lineages than super-enhancers. Moreo-
ver, H3K4me3 broad peaks are also found to specifically 
associate with tumor-suppressor genes, which are conserved 
in many cell types (Chen et al., 2015). This indicates that 
different broad epigenetic marks play different roles in reg-
ulating gene expression. 
SUPER-ENHANCER DATABASE 
With research interest on super-enhancers increase, more 
and more super-enhancers are defined in different cell 
types. Several tools have emerged to integrate and annotate 
those super-enhancers. Super-Enhancer Archive (SEA), 
integrated 83996 super-enhancers in 134 cell types or tis-
sues or diseases in different organisms, such as human, 
mouse, Drosophila and C. elegans (Wei et al., 2016). Most 
of these super-enhancers are computationally identified and 
some of them are experimentally validated. SEA can sup-
port multiple search options, which provide annotations like 
TF binding sites, CRISPR/Cas9 target sites, SNPs and so 
on. 
Another super-enhancer data base called dbSUPER also 
integrates super-enhancers in more than 100 cell types 
(Khan and Zhang, 2016). Different from SEA, users can 
upload their data to dbSUPER to find and compare su-
per-enhancers. These data can also be easily sent to other 
tools for further analysis, such as GREAT and Cistrome 
web-servers. 
The above databases provide a useful resource for ex-
ploring the function of super-enhancers. 
SUMMARY 
By definition, super-enhancer is a large cluster of enhanc-
ers. Some super-enhancer contains only one constituent 
enhancer, which means that super-enhancers are not neces-
sarily clusters of enhancers. The current definition of a su-
per enhancer as a large domain of peaks is operational ra-
ther than functional. A functional definition of super en-
hancers still awaits further mechanistic studies of them in 
many different biological contexts. Moreover, what is the 
role of each individual enhancer within super-enhancer, and 
how do they cooperate together to regulate gene expression 
are still questions to be answered. 
With the development of CRISPR/Cas9 technology, it is 
now possible to investigate the cooperative roles of indi-
vidual enhancers within super-enhancers by specifically 
knocking-out an individual enhancer. Also 3D genome 
technology will depict a more structural and mechanistic 
view of super-enhancer in regulating gene expression. 
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